| 000 | 01759 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515074433.0 | ||
| 264 | 0 | _c20080711 | |
| 008 | 200807s 0 0 chi d | ||
| 022 | _a0578-1426 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Hong-zhou | |
| 245 | 0 | 0 |
_a[A cross-sectional case study of human immunodeficiency virus and tuberculosis co-infection in mainland China]. _h[electronic resource] |
| 260 |
_bZhonghua nei ke za zhi _cApr 2007 |
||
| 300 |
_a280-3 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aZhang, Yue-xin | |
| 700 | 1 | _aZhou, Zeng-quan | |
| 700 | 1 | _aYe, Han-hui | |
| 700 | 1 | _aZhao, Qing-xia | |
| 700 | 1 | _aWang, Hui | |
| 700 | 1 | _aWang, Fu-xiang | |
| 700 | 1 | _aJia, Wang-qian | |
| 700 | 1 | _aSun, Hong-qing | |
| 700 | 1 | _aJiang, Xue-yan | |
| 700 | 1 | _aDing, Li-min | |
| 700 | 1 | _aSu, Yan | |
| 700 | 1 | _aHe, Yun | |
| 700 | 1 | _aMaimaitiaili, Wubuer | |
| 700 | 1 | _aYibaguli, Aibaidoula | |
| 700 | 1 | _aSun, Xiao-feng | |
| 700 | 1 | _aLiu, Bao-rong | |
| 700 | 1 | _aHu, Ya-dong | |
| 700 | 1 | _aTang, Wei | |
| 700 | 1 | _aZhou, Bo-ping | |
| 700 | 1 | _aCao, Yun-zhen | |
| 773 | 0 |
_tZhonghua nei ke za zhi _gvol. 46 _gno. 4 _gp. 280-3 |
|
| 999 |
_c17171737 _d17171737 |
||